High expression of arachidonate 15-lipoxygenase and proinflammatory markers in human ischemic heart tissue

Biochemical and Biophysical Research Communications

Volumn 424, Issue 2, 2012, Pages 327-330

  Magnusson, Lisa U ^a   Lundqvist, Annika ^a   Asp, Julia ^b   Synnergren, Jane ^c   Johansson, Cecilia Thalén ^a   Palmqvist, Lars ^b   Jeppsson, Anders ^d   Hultén, Lillemor Mattsson ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c UNIVERSITY OF SKÖVDE   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Arachidonate 15 lipoxygenase; Cardiac tissue; Ischemia

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA;

ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE MARKER; HEART MUSCLE; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANOXIA; ARACHIDONATE 15-LIPOXYGENASE; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIUM;

MAMMALIA;

EID: 84864314938     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.06.117     Document Type: Article

References (29)

1. Semenza G.L. Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp. Physiol. 2006, 91(5):803-806.
2. Semenza G.L. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem. J. 2007, 405(1):1-9.
3. Semenza G.L. Life with oxygen. Science 2007, 318(5847):62-64.
4. Oliver K.M., Taylor C.T., Cummins E.P. Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases. Arthritis Res. Ther. 2009, 11(1):215.
5. Taylor C.T. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J. Physiol. 2008, 586(Pt 17):4055-4059.
6. Rius J., Guma M., Schachtrup C., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453(7196):807-811.
7. Hulten L.M., Olson F.J., Aberg H., et al. 15-Lipoxygenase-2 is expressed in macrophages in human carotid plaques and regulated by hypoxia-inducible factor-1alpha. Eur. J. Clin. Invest. 2010, 40(1):11-17.
8. Gertow K., Nobili E., Folkersen L., et al. 12- and 15-lipoxygenases in human carotid atherosclerotic lesions: associations with cerebrovascular symptoms. Atherosclerosis 2011, 215(2):411-416.
9. Conrad M., Sandin A., Forster H., et al. 12/15-lipoxygenase-derived lipid peroxides control receptor tyrosine kinase signaling through oxidation of protein tyrosine phosphatases. Proc. Natl. Acad. Sci. USA 2010, 107(36):15774-15779.
10. Spiteller G. Peroxyl radicals: inductors of neurodegenerative and other inflammatory diseases. Their origin and how they transform cholesterol, phospholipids, plasmalogens, polyunsaturated fatty acids, sugars, and proteins into deleterious products. Free Radic. Biol. Med. 2006, 41(3):362-387.
11. Hedrick C.C., Kim M.D., Natarajan R.D., Nadler J.L. 12-Lipoxygenase products increase monocyte:endothelial interactions. Adv. Exp. Med. Biol. 1999, 469:455-460.
12. Asp J., Synnergren J., Jonsson M., Dellgren G., Jeppsson A. Comparison of human cardiac gene expression profiles in paired samples of right atrium and left ventricle collected in vivo. Physiol. genom. 2012, 44(1):89-98.
13. Schmittgen T.D., Livak K.J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protocol. 2008, 3(6):1101-1108.
14. Moslehi J., Minamishima Y.A., Shi J., et al. Loss of hypoxia-inducible factor prolyl hydroxylase activity in cardiomyocytes phenocopies ischemic cardiomyopathy. Circulation 2010, 122(10):1004-1016.
15. Ge J., Zhao G., Chen R., et al. Enhanced myocardial cathepsin B expression in patients with dilated cardiomyopathy. Eur. J. Heart Fail. 2006, 8(3):284-289.
16. Honn K.V., Timar J., Rozhin J., et al. A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells. Exp. Cell Res. 1994, 214(1):120-130.
17. Benchoua A., Braudeau J., Reis A., Couriaud C., Onteniente B. Activation of proinflammatory caspases by cathepsin B in focal cerebral ischemia. J. Cerebr. Blood Flow Metabol. 2004, 24(11):1272-1279.
18. Montecucco F., Braunersreuther V., Lenglet S., et al. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. Eur. Heart J. 2011, 10.1093/eurheartj/ehr127.
19. Danielsson K.N., Rydberg E.K., Ingelsten M., et al. 15-Lipoxygenase-2 expression in human macrophages induces chemokine secretion and T cell migration. Atherosclerosis 2008, 199:34-40.
20. Combadiere C., Potteaux S., Rodero M., et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 2008, 117(13):1649-1657.
21. Kuhlicke J., Frick J.S., Morote-Garcia J.C., Rosenberger P., Eltzschig H.K. Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxia. PLoS ONE 2007, 2(12):e1364.
22. Jacquet S., Nishino Y., Kumphune S., et al. The role of RIP2 in p38 MAPK activation in the stressed heart. J. Biol. Chem. 2008, 283(18):11964-11971.
23. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the toll signaling pathway. Nat. Immunol. 2001, 2(9):835-841.
24. Mann D.L. The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls. Circ. Res. 2011, 108(9):1133-1145.
25. Kim J., Shao Y., Kim S.Y., et al. Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway. Mol. Biol. Cell 2008, 19(2):433-444.
26. Hartford M., Wiklund O., Hulten L.M., et al. Interleukin-18 as a Predictor of Future Events in Patients With Acute Coronary Syndromes. Arterioscler. Thromb. Vasc. Biol. 2010, 30(10):2039-2046.
27. Kehmeier E.S., Lepper W., Kropp M., et al. TNF-alpha, myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention. Clin. Res. Cardiol. (Official J. German Cardiac Soc.) 2012, 10.1007/s00392-012-0465-x.
28. Wu M.Y., Lin T.H., Chiu Y.C., Liou H.C., Yang R.S., Fu W.M. Involvement of 15-lipoxygenase in the inflammatory arthritis. J Cell Biochem 2012, 113(7):2279-2289.
29. Wen Y., Gu J., Chakrabarti S.K., et al. The role of 12/15-lipoxygenase in the expression of interleukin-6 and tumor necrosis factor-alpha in macrophages. Endocrinology 2007, 148(3):1313-1322.